Medtronic snagged FDA approval for an expanded indication for its OmniaSecure defibrillation lead. Check out why this tiny ...
Built for high reliability, world's only lumenless defibrillation lead approved for placement in the left bundle branch area GALWAY, Ireland, March 23, 2026 /PRNewswire/ -- Medtronic plc ...
Medical Device Network on MSN
Medtronic’s OmniaSecure defib lead nets another FDA approval
OmniaSecure is now the first defibrillation lead approved for placement in the left bundle branch.
DUBLIN, Jan. 5, 2024 /PRNewswire/ -- Medtronic plc (MDT), a global leader in healthcare technology, today announced it has received CE (Conformité Européenne) Mark for its Micra™ AV2 and Micra™ VR2, ...
Medtronic Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms
EV-ICD defibrillation lead placed outside of heart and veins, preserving vasculature DUBLIN, Feb. 17, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT) has received CE (Conformité Européenne) Mark for the ...
Medtronic was the only manufacturer of a leadless pacemaker in the U.S. market in the years after it won approval for its Micra device in 2016. While leadless pacemakers were designed to prevent lead- ...
First-of-its-kind Aurora EV-ICD™ system offers single device, single procedure with lead placed outside of heart and veins DUBLIN, Oct. 23, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global ...
DUBLIN, May 1, 2023 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of its Micra™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results